The influence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modified with solutol HS 15.

Arachis oil based parenteral O/W emulsions were prepared using soya bean phosphatidylcholine (SPC) and different combinations of co-emulsifiers containing polyethylene glycol fatty acid esters (Solutol HS 15) and alkali fatty acids (sodium laurate, sodium stearate). The parameters measured were droplet size (both by photon correlation spectroscopy and laser diffractometry), pH and zeta potential. All emulsions were subjected to autoclaving. The addition of polyethylene glycol 12-hydroxy stearate (Solutol HS 15) led to a significant decrease of mean oil droplet size. For long-term stability the amount added turned out to be the most important factor. With increased amounts of Solutol HS 15 the packing density of the emulsifier layer and the zeta potential decreased leading to instability. The optimum load of Solutol HS 15 was found to be 15 micromol/ml. Alkali fatty acids markedly improved the physical stability of the emulsions. Improved stability properties conferred to emulsions by alkali fatty acids could be attributed to the zeta potential increase even in the presence of Solutol HS 15. Consequently a mixed emulsifier film was established in which the ionized fatty acids determined the interface charge. In addition to this a strengthening of the molecular interactions occurring between phospholipid and Solutol HS 15 emulsifier in the presence of ionized fatty acids at the O/W interface can be assumed (L. Rydhag, The importance of the phase behaviour of phospholipids for emulsion stability, Fette Seifen Anstrichm. 81 (1979) 168-173). Different co-emulsifier mixtures were shown to have a pronounced impact on the plasma protein adsorption onto emulsion droplets.     

Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions

The physicochemical properties of soy bean oil emulsions stabilized with purified egg lecithins (phosphatides) of various concentrations have been examined. The zeta potential of the emulsion droplets and the mean particle size of oil droplets in 10% (w/w) o/w-type emulsion decreased with increasing emulsifier concentration and then levelled off at more than 1.2% (w/w). In rheological measurements, at the initial stage, the viscosity of 10% (w/w) o/w-type emulsion gradually increased with increasing purified egg lecithin concentration, at the next stage, a plateau was reached at about 1.0-1.4% (w/w), and at the final stage, the viscosity curve showed a dramatic increase. These results indicate that emulsions stabilized by purified egg lecithin at more than 1.2% (w/w) are likely to be sufficiently stable.     

处方因素对亚微乳物理稳定性的影响

目的 初步探讨亚微乳处方中乳化剂及油相因素对其物理稳定性的影响.方法 采用高速剪切分散和高压均质乳化工艺制备亚微乳,单因素试验法考察处方中乳化剂与油相对亚微乳物理稳定性的影响;以平均粒径、D50值、D99值及ζ电位为指标,考察不同处方中亚微乳灭菌前后的物理稳定性,并留样观察其长期稳定性.结果 泊洛沙姆188与中链油相互配伍不能得到性质稳定的亚微乳,且单独以泊洛沙姆188为乳化剂的各处方制剂长期放置后平均粒径明显增大;聚乙二醇硬脂酸酯( HS15)与各油相结合制得的亚微乳均较稳定,长期放置后各项指标基本不变;聚山梨酯80与大豆油-中链油(1∶1)混合油或大豆油配伍制成的亚微乳在灭菌后产生较大粒径的乳滴,而与中链油相配伍可制得粒径较小且均匀分散的体系;蛋磷脂E80单独作为亚微乳乳化剂,乳化效果欠佳.结论 大豆油、中链油及混合油与不同性质的乳化剂相互作用可共同影响亚微乳的粒径,但不同制剂的处方对亚微乳ζ电位无显著影响.     

Effect of methylcellulose on the stability of oil-in-water emulsions

The objective of this study was to investigate how polymers used as auxiliary emulsifiers improve the stability of oil-in-water emulsions. One stable emulsion and three unstable emulsions were formulated with 30% mineral oil and an emulsifier blend of Tween® 40 and Span® 20. The stable emulsion (SE) contained 2% emulsifier blend optimized for maximum stability. One unstable emulsion, UEI, was formulated to contain 0.5% of the same emulsifier blend as the SE formulation. Two unstable emulsions were formulated to contain an unbalanced emulsifier blend, one with excessive hydrophilic emulsifier (UE2) and one with excessive lipophilic emulsifier (UE3). A series of emulsions was prepared containing increasing amounts of methylcellulose for each base emulsion. Creaming and change in particle size were measured to evaluate stability. The addition of the polymer to the stable emulsion caused instability leading to creaming and eventual oil separation. This effect of the polymer was more pronounced in UEI emulsions. However, the addition of the polymer improved the stability of the UE2 and UE3 series of emulsions. The polymer also caused a reduction in the particle size of UE3 emulsions and a proportionally larger increase in the viscosity of UE2 emulsions. These results suggest that (i) methylcellulose could act as a hydrophilic emulsifier only in the absence of Tween^® 40, (ii) methylcellulose and Tween^® 40 associate to form a complex and (iii) the concentration of Tween^® 40 is the determining factor for the stability of emulsions. A model of the methylcellulose-Tween^® 40 association and its effect at the mineral oil-water interface is proposed.     

Effect of methylcellulose on the stability of oil-in-water emulsions: influence of the disperse phase

The influence of nature of the disperse phase on the stability of oil-in-water emulsions containing nonionic emulsifiers and methylcellulose 4000 as an auxiliary emulsifier was investigated. One stable and three unstable base emulsions each of olive oil and of mineral oil were formulated with an emulsifier blend of Tween® and Span®. The stable emulsion (SE) contained 2% emulsifier blend optimized for maximum stability. Three unstable emulsions were formulated from the SE formulation: one with 0.5% emulsifier blend as of the SE formulation (UE1), one with excessive hydrophilic emulsifier (UE2) and one with excessive lipophilic emulsifier (UE3). A series of emulsions was prepared containing increasing amounts of methylcellulose 4000 for each base emulsion. The particle size of all olive oil emulsions was reduced (UE2>SE>UE3) and the viscosity was increased (UE2>SE>UE3) on addition of methylcellulose. The stability of these emulsions improved in the presence of methylcellulose. However, the addition of the polymer caused instability in mineral oil emulsions containing lower concentrations of the hydrophilic emulsifier (Tween®). These results suggest that: (i) methylcellulose and the hydrophilic emulsifier associate to form a complex; (ii) this complex when present at the mineral oil-water interface would be dislodged from the interface due to less interaction between the non-polar oil and the polyoxyethylene (POE) chain of the hydrophilic emulsifier; and (iii) this complex when present at the olive oil-water interface would stabilize emulsions due to higher interaction between the polar oil and the POE chain of the hydrophilic emulsifier.     

Stability of drug-carrier emulsions containing phosphatidylcholine mixtures.

Lipid emulsion particles containing 10% of medium chain triglycerides were prepared using 2% w/w of a mixture 1:1 w/w of purified soya phosphatidylcholine and 2-hexanoyl phosphatidylcholine as emulsifier mixture, for use as drug carriers. The mean droplet sizes of emulsions, prepared using an Ultra Turrax or a high-pressure homogenizer, were about 288 and 158 nm, respectively, compared with 380 and 268 nm for emulsions containing lecithin, or 325 and 240 nm for those containing 6-phosphatidylcholine. The stability of the emulsions, determined by monitoring the decrease of a lipophilic marker at a specified level within the emulsion, and observing coalescence over time, was also greatly increased using the emulsifier mixture. The emulsion stability did not notably change in the presence of a model destabilizing drug, indomethacin. The use of a second hydrophilic surfactant to adjust the packing properties of the lecithin at the oil-water interface provided an increase in the stability of lipid emulsions, and this may be of importance in the formulation of drug delivery systems.     

Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice

All-trans retinoic acid (ATRA) was incorporated into lipid emulsions in an attempt to alter its distribution characteristics and improve its inhibition of liver cancer metastasis. Lipid emulsions composed of egg phosphatidylcholine, cholesterol, and soybean oil were the optimized carriers for ATRA delivery, as shown by the submicron particle size and high incorporation efficiency. The particle size and zeta potential of ATRA incorporated into emulsions were about 133 nm and -11 mV, respectively. In vitro drug release study demonstrated that the release of ATRA from emulsions was sustained in the absence and present of bovine serum albumin, suggesting that ATRA was stable when incorporated in emulsions. After intravenous administration in mice, [3H]cholesteryl hexadecyl ether incorporated into emulsion, which is the inherent distribution of emulsions, accumulated gradually mainly in the liver. The blood concentration and hepatic accumulation of [3H]ATRA incorporated into emulsion was significantly higher than that of serum dissolving [3H]ATRA, which represent the original distribution characteristic of free ATRA. In a murine liver metastasis model by colon adenocarcinoma, the liver metastasis number and liver weight were significantly reduced and the survival time of mice was prolonged following intravenous injection of ATRA incorporated into emulsions.     

A novel stable supersaturated submicron lipid emulsion of tirilazad.

This paper describes a novel supersaturated submicron lipid emulsion for parenteral drug delivery. Tirilazad was used as an amphiphilic model drug for the preparation and characterization of the supersaturated emulsions with concentrations more than two times higher than the drug solubility in the emulsion. Analysis of particle size distribution using photon correlation spectroscopy indicated that the mean particle diameters of the supersaturated 10 and 20% lipid emulsions of tirilazad were approximately 210 and 240 nm, respectively, and that the mean particle size and size distribution of the supersaturated tirilazad emulsions were not different from those of the non-supersaturated tirilazad emulsions. The apparent viscosity of the supersaturated tirilazad emulsions, as measured by continuous rheometry, was similar to that of the non-supersaturated tirilazad emulsions. However, the zeta potential of the supersaturated tirilazad emulsions, as determined by the electrophoretic light-scattering technique, was found to be dependent on drug load and was lower than that of the non-supersaturated tirilazad emulsion. Fractionation by ultracentrifugation showed that at low drug loads, the amount of drug associated with the emulsion particles and the infranatant fraction appeared to increase linearly with increasing concentration of the drug. By contrast, the amount of drug associated with the emulsion particles increased rapidly, whereas the amount of drug associated with the infranatant fraction remained constant for emulsions with a high drug load. These results suggest that the excess drug in the supersaturated emulsions is largely associated with the lipid phase. Accelerated stability studies under stress conditions (i.e., autoclaving and shaking) and long-term storage stability tests demonstrated that the supersaturated tirilazad emulsions had excellent physical stability over the study period of 16 months.     

Oxidation of linoleic acid encapsulated with gum arabic or maltodextrin by spray-drying

Linoleic acid was emulsified with gum arabic or maltodextrin at various weight ratios of the acid to the polysaccharide in the presence or absence of a small-molecule emulsifier. The emulsions were spray-dried to produce microcapsules. Emulsions prepared with gum arabic were smaller in droplet size and more stable than those prepared with maltodextrin, and linoleic acid in a gum arabic-based microcapsule was also most resistant to oxidation than that in a maltodextrin-based microcapsule. Although the oil droplet size in the emulsion with maltodextrin decreased and the emulsion stability was improved by addition of a small-molecule emulsifier to linoleic acid, the oxidative stability of the encapsulated linoleic acid was not significantly improved. Encapsulated linoleic acid of small droplet size oxidized more slowly than that of large droplet size.     

Oxidation of linoleic acid encapsulated with gum arabic or maltodextrin by spray-drying

Linoleic acid was emulsified with gum arabic or maltodextrin at various weight ratios of the acid to the polysaccharide in the presence or absence of a small-molecule emulsifier. The emulsions were spray-dried to produce microcapsules. Emulsions prepared with gum arabic were smaller in droplet size and more stable than those prepared with maltodextrin, and linoleic acid in a gum arabic-based microcapsule was also most resistant to oxidation than that in a maltodextrin-based microcapsule. Although the oil droplet size in the emulsion with maltodextrin decreased and the emulsion stability was improved by addition of a small-molecule emulsifier to linoleic acid, the oxidative stability of the encapsulated linoleic acid was not significantly improved. Encapsulated linoleic acid of small droplet size oxidized more slowly than that of large droplet size.     

3-正丁基苯酞静脉注射亚微乳的制备和稳定性考察

目的制备3-正丁基苯酞(NBP)静脉注射亚微乳并考察其稳定性。方法采用高速剪切法制备初乳,二次高压均质法制备终乳。以灭菌前后乳剂的外观性状、粒径变化和稳定性常数(Ke)等为评价指标,考察制剂工艺的影响因素,同时采用正交设计实验优化处方。所得制剂分别在4、25、40℃条件下放置3个月,观察其外观性状、粒径、Zeta电位、pH值、药物含量、游离脂肪酸值和过氧化值等的变化。结果在优化处方及工艺条件下,所制备的NBP亚微乳稳定性良好,平均粒径为(128.0±3.4)nm(n=3),Zeta电位为-(34.3±5.3)mV(n=3)。稳定性实验结果表明,样品放置3个月后pH值降低约0.3,40℃条件下样品略变黄,其余各项指标无明显变化。结论该处方和工艺可行,制备的NBP亚微乳性质稳定,可供静脉使用。     

Factors influencing the tissue distribution of coenzyme Q10 intravenously administered in an emulsion to rats: emulsifying agents and lipoprotein lipase activity

The tissue distribution of coenzyme Q10 (CoQ10) administered intravenously in an emulsion prepared with egg yolk phosphatidylcholine (PC), egg yolk sphingomyelin (SPM) or a combination of PC and a polyoxyethylene derivative of hydrogenated castor oil (HCO-60) (PC + HCO-60) was investigated. The disappearance from the plasma of CoQ10 administered in three different emulsions of lipid particle size less than 0.5 micron varied with the particular emulsifier. Its disappearance occurred most rapidly from the PC emulsion; with the addition of HCO-60, its disappearance was much slower. In the reticuloendothelial system, the concentration of CoQ10 was higher in the spleen, for both the SPM and PC + HCO-60 emulsions than for the PC emulsion. HCO-60 reduced the CoQ10 distribution in the liver from the PC emulsion. Differences in disappearance rates from the plasma are thus considered to be due to the extent of CoQ10 distribution in the liver. CoQ10 concentration in the heart, a target organ, was greatest with the PC emulsion. Its distribution was related to lipoprotein lipase (LPL) activity in this organ. The effects caused by HCO-60, however, could not be explained by LPL activity alone. CoQ10 distribution in the adrenal gland and kidney can be explained partly by LPL activity but in the presence of HCO-60, the distribution mechanism apparently involves other factors.     

Physical Characterization of Halofantrine-Encapsulated Fat Nanoemulsions

We report the colloidal characterization of halofantrine (Hf)-laden soybean oil fat emulsions. Hf increased the zeta potential, at all pH values, of the fat emulsions. Concomitant with this, the isoelectric point (i.e.p.) of the emulsion increased to higher pH values. The emulsion was destabilized by a small amount of Hf; interestingly, however, this was ameliorated by increasing the amount of Hf. The particle size and polydispersity of the fat emulsion reflected this with a small Hf concentration resulting in a significant increase in both particle size and polydispersity, but less so as the Hf concentration was increased. Emulsions lost stability as the pH approached the i.e.p. and this effect was greatest for the small Hf concentration emulsions. Cryogenic transmission electron microscopy showed the presence of beading or string-like behavior leading to gross distortions of the spherical shape for highly unstable emulsions. We conclude that to maintain good stability for Hf-laden soybean oil emulsions, the pH of the emulsion should be kept away from its i.e.p, and also that the drug concentration should be maintained at a relatively high value.     

An assessment of techniques for evaluating the physical stability of parenteral emulsions

The physical stability of the parenteral emulsions is a key product quality issue. The purpose of this study is to develop, prepare and characterize model phospholipid emulsions and to critically evaluate various physical stability-indicating methods. Oil-in-water (O/W) emulsions were prepared using 20% (w/w) medium chain triglycerides (MCT) or soybean oil in 2.21% (w/w) aqueous glycerin solutions emulsified with 0.1 to 1.8 % (w/w) lecithin. The reproducibility of emulsion preparation was determined by measuring the volume-based mean droplet diameter using photon correlation spectroscopy (PCS) and zeta potential using electrophoretic light scattering. Evaluation of stability-indicating methods was conducted by comparing the mean droplet growth rate of a thermally-stressed emulsion using PCS, a light obscuration particle counter (HIAC, equipped with a laser diode sensor) and a droplet image analyzer interfaced with transmission electron microscopy (TEM) using osmium tetraoxide fixation. Emulsions with identical compositions and preparation properties had reproducible mean droplet diameter and initial zeta potential values with RSD < 5.0%. Upon the application of thermal stress, the volume-based diameter increased linearly with time for all three sizing techniques (PCS, HIAC, and TEM). The droplet growth rates estimated using PCS and TEM were nearly identical. PCS is a sufficiently accurate technique for measuring emulsion stability and is less time-consuming than TEM. The HIAC technique only measured the size of droplets with diameters larger than about 1 micron, which was considerably greater than the mean droplet diameter as determined by PCS and microscopic image analysis (TEM). Moreover, the growth rate obtained using HIAC was much greater than the rates estimated by PCS and TEM; therefore the HIAC technique was not an accurate measure of the physical stability of the thermally stressed emulsions.     

Long-Circulating Multiple-Emulsion System for Improved Delivery of an Anticancer Agent

Stealth multiple emulsions of small size, containing 6-mercaptopurine, were prepared by incorporation of sphingomyelins (SM) and monosialogangliosides (GM1) in the oily phase and by coating with lipid-grafted polyethylene glycol (PEG-PC). The three types of "stealth" multiple emulsions were characterized for size distribution, zeta potential, viscosity, encapsulation efficiency, drug release, and stability. Drug disposition studies were performed with formulated multiple emulsions to assess "stealth" behavior. The tissue distribution studies were carried out with the PEG grafted multiple emulsion. The results suggest that PEG-PC-coated multiple emulsions are superior as prolonged release and extended bloodcirculating carriers compared to multiple emulsions bearing either SM or GM1.     

Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition,drug concentration and storage temperature

Abstract

Paclitaxel was loaded into licensed parenteral nutrition nanoemulsions (Clinoleic® and Intralipid®) using bath sonication, and the stability of the formulations was investigated following storage for two weeks at room temperature or at 4?°C. In general, Clinoleic droplets were smaller than Intralipid droplets, being around 255 and 285?nm, respectively, for blank and freshly loaded emulsions. Regardless of storage temperature, the Clinoleic exhibited a very slight or no increase in droplet size upon storage, whilst the droplet size of the Intralipid emulsion increased significantly. The droplet size of both emulsions was minimally affected by paclitaxel concentration within the range of 0, 1, 3 and 6?mg/ml. The pH of both emulsions markedly decreased upon storage at room temperature, which was possibly attributed to the production of fatty acids resulting from phospholipid hydrolysis. However, at 4?°C, the pH of Clinoleic emulsion was unaffected by storage or paclitaxel concentration while the Intralipid emulsion demonstrated a trend for pH reduction. Both nanoemulsions had a negative zeta potential, with the Clinoleic formulations having the highest charge, possibly explaining the better size stability of this emulsion. Overall, this study has shown that paclitaxel was successfully loaded into clinically licensed parenteral emulsions and that Clinoleic showed greater stability than the Intralipid.     

An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier

Multiple W/O/W emulsions with high content of inner phase (Phi1=Phi2=0.8) were prepared using relatively low concentrations of lipophilic polymeric primary emulsifier, PEG 30-dipolyhydroxystearate, and diclofenac diethylamine (DDA) as a model drug. The investigated formulations were characterized and their stability over the time was evaluated by dynamic and oscillatory rheological measurements, microscopic analysis and in vitro drug release study. In vitro release profiles of the selected model drug were evaluated in terms of the effective diffusion coefficients and flux of the released drug. The multiple emulsion samples exhibited good stability during the ageing time. Concentration of the lipophilic primary emulsifier markedly affected rheological behaviour as well as the droplet size and in vitro drug release kinetics of the investigated systems. The multiple emulsion systems with highest concentration (2.4%, w/w) of the primary emulsifier had the lowest droplet size and the highest apparent viscosity and highest elastic characteristics. Drug release data indicated predominately diffusional drug release mechanism with sustained and prolonged drug release accomplished with 2.4% (w/w) of lipophilic emulsifier employed.     

Impact of the type of emulsifier on the physicochemical characteristics of the prepared fish oil-loaded microcapsules

Fish oil microcapsules were successfully prepared from fish oil-in-water emulsions using chitosan as shell material and anionic surfactants sodium dodecyl sulphate (SDS), sodium dodecylbenzenesulfonate (SDBS), sodium cholate (cholate), and sodium deoxycholate (DOC) as emulsifiers. The type of emulsifier influenced the physicochemical characteristics of the prepared microcapsules to different extents. The microcapsules formed with DOC showed the least mean effective diameter (MED) of 500?nm. Emulsion formed with DOC exhibited the smallest MED of 100?nm. The emulsions showed negative zeta potential values which became positive after encapsulation with chitosan. The surfactants showed little influence on thermal stability. Microcapsule suspensions showed creaming over storage. Fish oil at higher loading in SDS microcapsules showed higher primary and secondary oxidation. All microcapsules showed sustained release but the values varied depending upon the surfactants. The emulsion and microcapsules formed with DOC showed better morphology and stability despite its lower loading and encapsulation efficiency.     

Stability of total nutrient admixtures using various intravenous fat emulsions

The stability of four lipid emulsions with amino acids and dextrose in total nutrient admixtures (TNAs) was studied. The admixtures were divided into three groups. In group 1, 24 admixtures representing 20 different combinations of Liposyn II (safflower oil-soybean oil fat emulsion) with various manufacturers' amino acids (FreAmine III, Travasol, Novamine, Nephramine, and RenAmin) were tested. In group 2, 19 TNAs representing 14 combinations containing soybean-oil emulsions (Intralipid, Travamulsion, and Soyacal) and Aminosyn II amino acids were studied. In group 3, 14 TNAs representing 9 combinations containing the above soybean oil emulsions and Aminosyn II with Electrolytes were tested. Both 10% and 20% concentrations of fat emulsion, various amino acid concentrations ranging from 5.4% to 11.4%, and dextrose injections of 10, 20, 40, 50, and 70% were used. The admixtures were compounded in an ethylene vinyl acetate container. The mixing sequence involved transfer of fat emulsion to the empty container, followed by amino acids and dextrose. One of two electrolyte and trace metal profiles was added to each core admixture after compounding. Multivitamins were added just before the 24-hour room-temperature (25 +/- 4 degrees C) storage. Admixtures were tested initially and after one day at room temperature or nine days at 5 degrees C plus one day at room-temperature storage. Measurements of pH, emulsion particle size, osmolality, and zeta potential (electrostatic surface charge of lipid particles) were made after visual inspection of each admixture. In general, the TNAs retained a uniform, milk-like appearance under both storage conditions. The values of pH, zeta potential, particle size, and osmolality remained essentially unchanged throughout the study. Under the conditions of this study, the TNA formulations tested are stable for up to 10 days.     

Effect of camphor/cyclodextrin complexation on the stability of O/W/O multiple emulsions

Camphor (CA) encapsulation in oil/water/oil multiple emulsions prepared with cyclodextrin disturbs the emulsifier potential of alpha- and beta-natural cyclodextrins (CD). It was suggested that the size and geometrical fit between the CD cavity and CA could induce CD/CA complex formation in place of emulsifier formation leading to perturbation of emulsion stability. The complexation between CA and alpha-, beta- or gamma-CD in solution in the presence of oil phase are confirmed by phase-solubility diagrams, circular dichroism and 1H NMR. Furthermore, in order to mimic the emulsion system, CD/CA/soybean oil ternary dispersions were prepared to observe the complexation behavior of alpha-, beta- or gamma-CD/CA by circular dichroism. X-ray diffraction on emulsion samples prepared with alpha- and beta-CD confirms that the precipitates observed in emulsions are probably composed of crystals of CD/CA complexes. A preliminary study of the interaction between drug and CD before the formulation seems indispensable to prevent the risk of incompatibility.